Effects of MCI-727, a New Anti-Ulcer Agent, on Plasma Secretin Concentration in Rats and Dogs and Pancreatic Exocrine Secretion in Rats.
スポンサーリンク
概要
- 論文の詳細を見る
In the present study, we investigated the effects of MCI-727, a new anti-ulcer agent, on plasma immunoreactive secretin concentration in rats and dogs using secretin specific RIA with the ethanol extraction method. Plasma secretin levels were increased dose-dependently 10 min after oral administration of MCI-727 in rats (control: 5.5 ± 0.6; MCI-727, 10 mg/kg: 10.4 ± 2.6; 30 mg/kg: 15.3 ± 1.5; 100 mg/kg: 20.7 ± 2.6 pg/ml, n = 6). Teprenone also caused a significant increase of plasma secretin at 10 min after oral administration at the doses of 30, 100 and 300 mg/kg. Under the same conditions, MCI-727 and teprenone did not alter the plasma immunoreactive gastrin concentration in rats. From the results of the time course study, the increasing effect of MCI-727 (30 mg/kg, p.o.) on plasma secretin remained for at least 240 min after administration. On the other hand, the increasing effect of teprenone (200 mg/kg, p.o.) was only observed at 30 and 60 min after administration. Furthermore, MCI-727 had increasing effects on plasma secretin concentration in dogs, but teprenone had no effects in this species. The volume of pancreatic secretion and the pancreatic bicarbonate output increased after intra-duodenal administration of MCI-727 at 30 and 100 mg/kg in rats. Similar effects were also observed with teprenone (30-300 mg/kg, i.d.) or secretin (Secrepan®, 0.1-1.0 unit/kg, i.v.).
- 公益社団法人 日本薬理学会の論文
著者
-
TOBE Akihiro
Pharmaceuticals Laboratory, Research Center, Mitsubishi Kasei Co.
-
Takeuchi Tadashi
Department Of Gastroenterology Tokyo Women's Medical University School Of Medicine
-
WATANABE Shin-ichiro
Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical College
-
Watanabe Shin-ichiro
Department of Applied Biological Chemistry, Faculty of Agriculture, Tohoku University:(Present)P.C. Center
-
Kawamura Makoto
Pharmaceuticals Laboratory, Life Science Research Sector, Research Center, Mitsubishi Kasei Corporation
-
Yamazaki Satoshi
Pharmaceuticals Laboratory, Life Science Research Sector, Research Center, Mitsubishi Kasei Corporation
-
Takeuchi Tadashi
Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical College
-
Tobe Akihiro
Pharmaceuticals Laboratory, Life Science Research Sector, Research Center, Mitsubishi Kasei Corporation
関連論文
- Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally
- Effect of a Novel Cholecystokinin Receptor Antagonist, FK480, Administered Intraduodenally, on Pancreatic Secretion in Rats
- Effect of Cholecystokinin_1 Receptor Antagonist Loxiglumide (CR1505) on Basal Pancreatic Exocrine Secretion in Conscious Rats
- AGONIST ACTIVITY OF A NOVEL COMPOUND, BP-554,AT CENTRAL SEROTONIN-1A RECEPTORS
- Pyrolytic Elimination of 1-Ary1-2-(trimethylsilyl)ethyl Acetates via Two Distinct Pathways
- An Endothelial Nitric Oxide Synthase Inhibitor Aggravates CDL-Induced Acute Pancreatitis in Rats
- Development of Lipid Synthesis from CO_2 in Avena Leaves during Greening of Etiolated Seedlings
- 導電助剤としてカーボンを用いたNi-MH二次電池
- A New Staining Method for Use in Electrophoretic Determination of α-Amylase Isoenzymes in Serum
- Effects of MCI-727, a New Anti-Ulcer Agent, on Plasma Secretin Concentration in Rats and Dogs and Pancreatic Exocrine Secretion in Rats.
- Vascular effects of betaxolol, a cardioselective .BETA.-adrenoceptor antagonist, in isolated rat arteries.
- A new type of extra-large film changer for serial whole limb aorto-arteriography and its clinical applications.
- Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
- Effects of betaxolol on cardiohemodynamics and coronary circulation in anesthetized dogs: Comparison with atenolol and propranolol.
- Effects of MCI-727, a New Antiulcer Agent, on Various Gastric and Duodenal Lesions in Experimental Animals.
- Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs.
- Silicon Effects. II. Structure and Stability of 1-Phenyl-2-(trimethylsilyl)ethyl Cation in Solution.